Institute of Human Genetics, University Hospital Otto-von-Guericke- University Magdeburg, Magdeburg, Germany.
Department of Pediatric Surgery, Protestant Hospital of Bethel Foundation, University Hospital OWL, University of Bielefeld, Bielefeld, Germany.
Front Endocrinol (Lausanne). 2022 Oct 21;13:1015244. doi: 10.3389/fendo.2022.1015244. eCollection 2022.
The focal form of CHI is caused by an autosomal recessive pathogenic variant affecting the paternal homologue of genes or and a second somatic event specifically occurring in the affected islet of Langerhans. The approach of this study was to integrate the genetic changes occurring in pancreatic focal lesions of CHI at the genomic and transcriptional level.
Patients receiving therapeutic surgery and with proven or pathogenic variants were selected and analyzed for loss of heterozygosity (LOH), changes in copy number and uniparental disomy (UPD) on the short am of chromosome 11 by molecular microarray analysis and methylation-specific MLPA. Gene expression was analyzed by RT-PCR and Massive Analysis of cDNA Ends (MACE).
Both genes, and , are located in proximity to the Beckwith-Wiedemann (BWS) imprinting control region on chromosome 11p15. Somatic paternal uniparental isodisomy (UPD) at chromosome 11p was identified as second genetic event in focal lesions resulting in LOH and monoallelic expression of the mutated alleles. Of five patients with samples available for microarray analysis, the breakpoints of UPD on chromosome 11p were different. Samples of two patients were analyzed further for changes in gene expression. Profound downregulation of growth suppressing genes and was detected in focal lesions whereas growth promoting gene and pancreatic transcription factors of the endocrine cell lineage were upregulated.
Paternal UPD on the short arm of chromosome 11 appears to be the major second genetic event specifically within focal lesions of CHI but no common breakpoint for UDP can be delineated. We show for the first time upregulation of growth promoting (achaete-scute homolog 2) suggestive of a driving factor in postnatal focal expansion in addition to downregulation of growth suppressing genes and .
局灶性胰岛细胞增生症(CHI)的局灶形式是由影响 或 基因父源同源物的常染色体隐性致病性变异和特定发生在受影响的胰岛郎格汉斯岛的第二个体细胞事件引起的。本研究的方法是整合 CHI 胰腺局灶病变在基因组和转录水平上发生的遗传变化。
选择接受治疗性手术且具有明确的 或 致病性变异的患者,并通过分子微阵列分析和甲基化特异性 MLPA 分析 11 号染色体短臂上的杂合性丢失(LOH)、拷贝数变化和单亲二体(UPD),分析 11 号染色体短臂上的杂合性丢失(LOH)、拷贝数变化和单亲二体(UPD)。通过 RT-PCR 和大规模 cDNA 末端分析(MACE)分析基因表达。
和基因都位于 11 号染色体 11p15 的 Beckwith-Wiedemann(BWS)印迹控制区附近。在局灶病变中,第二个遗传事件是 11 号染色体上的体细胞父源单亲二体性(UPD),导致 LOH 和突变的等位基因的单等位基因表达。在五个可用于微阵列分析的患者样本中,11p UPD 的断点不同。进一步分析了两名患者的样本的基因表达变化。在局灶病变中,生长抑制基因和的表达明显下调,而生长促进基因和内分泌细胞谱系的胰腺转录因子上调。
11 号染色体短臂上的 UPD 似乎是 CHI 局灶病变中主要的第二个遗传事件,但不能划定 UDP 的共同断点。我们首次显示生长促进基因(achaete-scute 同源物 2)的上调,提示除了生长抑制基因和的下调外,在出生后局灶扩张中存在驱动因素。